Xenon Pharmaceuticals Inc. ($XENE)
Filing Information
| Accession Number | 0001193125-26-001172 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 2, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
120,000
Total Value
$2,076,692.86
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Shares | โ | Jan 2, 2026 | Exercise/Conversion | 40,000 | $7.49 | $299,600.00 | 46,000 | Direct | โ | View Details | |
Director | Common Shares | โ | Jan 2, 2026 | Sale | 37,938 | $44.40 | $1,684,447.20 | 8,062 | Direct | โ | View Details | |
Director | Common Shares | โ | Jan 2, 2026 | Sale | 2,062 | $44.93 | $92,645.66 | 6,000 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Exercise/Conversion | 40,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |